NOV 06, 2019 11:16 AM PST

Cone Snail Venom Became and Pain Therapeutics

WRITTEN BY: Nouran Amin

Ever heard of conotoxins? They are bioactive peptides present in the venom of the predatory marine cone snails that are well known for their effective envenomation strategy. The conotoxins help these snails to capture prey and defend themselves against predators.

The carnivorous sea slugs are known for their poisoning mechanism, which helps the animals catch and defend their prey such as fish or shells. (© Markus Muttenthaler)

"Cone snails can control their venom composition depending if they hunt or defend themselves," says Markus Muttenthaler from the Institute of Biological Chemistry at the University of Vienna. "For pain research, we are particularly interested in the venom of a defending cone snail, as its composition is aimed at causing pain and its individual components can be used to study pain pathways," the ERC Starting Grant awardee states.

They were used to study pain signaling and hold the potential to become a new class of drugs under the analgesics—because of these studies there are 10,000+ conotoxin’s that have been identified.

"Conotoxins have revolutionised pain research since their extraordinary potency and selectivity enables us to study the individual subtypes of ion channels, which was not possible before," explains Markus Muttenthaler.

There has been one contoxin that received FDA-approval (Prialt®) for treating severe chronic pain. That particular drug can be administered via the spinal cord where it blocks pain being transmitted though an ion channel subtype -- "it is 1,000 times more potent than morphine and triggers no symptoms of dependence, which is a big problem with opioid drugs," says Muttenthaler. "This would enable us to intercept the pain signal before it is transmitted into the central nervous system."

Now, current studies on conotoxins can target nerve endings outside the spinal cord for safer administration of the therapeutics. Findings of the study were published in the journal "Chemical Reviews” and advances venom drug discovery.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
FEB 24, 2021
Drug Discovery & Development
How Caffeine Changes the Brain?
FEB 24, 2021
How Caffeine Changes the Brain?
Caffeine is the worlds most consumed psychoactive substance which includes coffee, cola or an energy drink. However, res ...
FEB 25, 2021
Drug Discovery & Development
Future COVID-19 Targets Rapidly Identified with Computer Simulations
FEB 25, 2021
Future COVID-19 Targets Rapidly Identified with Computer Simulations
A recent mechanism as detailed in the novel SARS-CoV2 that causes COVID-19 could help scientists find new therapeutics. ...
MAR 12, 2021
Drug Discovery & Development
Drug Starves Melanoma Tumors
MAR 12, 2021
Drug Starves Melanoma Tumors
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake ...
APR 27, 2021
Drug Discovery & Development
Natural Remedy Better than Steroids For COVID-19 Smell Loss
APR 27, 2021
Natural Remedy Better than Steroids For COVID-19 Smell Loss
An international group of olfactory experts have recommended against the use of steroid treatments for loss of smell rel ...
MAY 15, 2021
Drug Discovery & Development
New Drug Blocks Critical Step in Malaria Life Cycle
MAY 15, 2021
New Drug Blocks Critical Step in Malaria Life Cycle
According to the World Health Organization (WHO), in 2019, there were approximately 229 million cases of malaria around ...
MAY 27, 2021
Neuroscience
Research Less Likely to Be True is Cited More
MAY 27, 2021
Research Less Likely to Be True is Cited More
Researchers from the University of California San Diego have found that non-replicable data is cited 153 times more ofte ...
Loading Comments...